Syndax Pharmaceuticals (SNDX) PT Lowered to $28 at Baird
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $20.71 -0.34%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 23
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 23
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $28.00 (from $32.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- Climb Bio (CLYM) PT Raised to $25 at Baird
- Obayashi Corporation (1802:JP) PT Lowered to JPY3,300 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
